HC Wainwright set a $63.00 price objective on DENTSPLY SIRONA (NASDAQ:XRAY) in a research report report published on Monday, March 5th. The brokerage currently has a hold rating on the medical instruments supplier’s stock.
XRAY has been the subject of several other research reports. Deutsche Bank assumed coverage on shares of DENTSPLY SIRONA in a report on Friday, December 8th. They issued a buy rating and a $81.00 target price for the company. BidaskClub downgraded shares of DENTSPLY SIRONA from a hold rating to a sell rating in a report on Tuesday, January 23rd. Barrington Research upgraded shares of DENTSPLY SIRONA from a market perform rating to an outperform rating and set a $73.00 price objective for the company in a report on Monday, November 6th. Zacks Investment Research downgraded shares of DENTSPLY SIRONA from a hold rating to a sell rating in a report on Monday, January 8th. Finally, JPMorgan Chase & Co. upgraded shares of DENTSPLY SIRONA from a neutral rating to an overweight rating and set a $75.00 price objective for the company in a report on Wednesday, December 13th. Three research analysts have rated the stock with a sell rating, four have assigned a hold rating and nine have issued a buy rating to the stock. The company has an average rating of Hold and an average price target of $67.43.
DENTSPLY SIRONA (NASDAQ:XRAY) traded up $0.02 during trading on Monday, hitting $57.82. 166,292 shares of the company’s stock were exchanged, compared to its average volume of 2,365,707. DENTSPLY SIRONA has a 12-month low of $52.53 and a 12-month high of $68.98. The company has a market capitalization of $13,418.07, a price-to-earnings ratio of 21.96, a price-to-earnings-growth ratio of 2.55 and a beta of 1.21. The company has a debt-to-equity ratio of 0.24, a current ratio of 2.12 and a quick ratio of 1.46.
DENTSPLY SIRONA (NASDAQ:XRAY) last released its quarterly earnings data on Thursday, March 1st. The medical instruments supplier reported $0.82 earnings per share for the quarter, beating analysts’ consensus estimates of $0.81 by $0.01. DENTSPLY SIRONA had a negative net margin of 39.39% and a positive return on equity of 8.35%. The firm had revenue of $1.09 billion for the quarter, compared to analyst estimates of $1.06 billion. During the same period last year, the firm earned $0.67 earnings per share. The business’s quarterly revenue was up 9.5% compared to the same quarter last year. sell-side analysts forecast that DENTSPLY SIRONA will post 2.74 earnings per share for the current fiscal year.
The firm also recently announced a quarterly dividend, which will be paid on Friday, April 13th. Shareholders of record on Thursday, March 29th will be given a dividend of $0.0875 per share. The ex-dividend date of this dividend is Wednesday, March 28th. This represents a $0.35 dividend on an annualized basis and a yield of 0.61%. DENTSPLY SIRONA’s dividend payout ratio is presently -5.09%.
In other DENTSPLY SIRONA news, Director Eric Brandt sold 6,409 shares of the stock in a transaction dated Monday, January 8th. The shares were sold at an average price of $68.04, for a total transaction of $436,068.36. Following the completion of the transaction, the director now owns 12,073 shares in the company, valued at $821,446.92. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 1.99% of the stock is owned by company insiders.
Hedge funds have recently added to or reduced their stakes in the company. NuWave Investment Management LLC bought a new position in shares of DENTSPLY SIRONA in the fourth quarter valued at approximately $121,000. Massey Quick Simon & CO. LLC bought a new position in shares of DENTSPLY SIRONA in the third quarter valued at approximately $124,000. Focused Wealth Management Inc boosted its position in shares of DENTSPLY SIRONA by 79.2% in the fourth quarter. Focused Wealth Management Inc now owns 2,600 shares of the medical instruments supplier’s stock valued at $171,000 after acquiring an additional 1,149 shares during the period. First Interstate Bank bought a new position in shares of DENTSPLY SIRONA in the third quarter valued at approximately $164,000. Finally, Stock Yards Bank & Trust Co. bought a new position in shares of DENTSPLY SIRONA in the fourth quarter valued at approximately $203,000. Institutional investors own 96.80% of the company’s stock.
About DENTSPLY SIRONA
DENTSPLY SIRONA Inc is a manufacturer of professional dental products and technologies. The Company develops, manufactures, and markets solutions offering, including dental and oral health products, as well as other consumable medical devices. It operates through two segments: Dental and Healthcare Consumables, and Technologies.
Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.